US 11104719
Recombinant clusterin and use thereof in the treatment and prevention of disease
granted A61KA61K38/00A61K9/0019
Quick answer
US patent 11104719 (Recombinant clusterin and use thereof in the treatment and prevention of disease) held by The Board of Regents of the University of Texas System expires Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Aug 31 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Aug 26 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 21
- CPC classes
- A61K, A61K38/00, A61K9/0019, A61K9/19, A61P